Organon

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$6.14-$15.92
Market Cap
$1.9B
Shares Short
17M

Financials

See more
Revenue (12 Mos)
$6.2B
Revenue Growth (YoY)
-5.3%
Gross Profit (12 Mos)
$3.3B
Diluted EPS
$0.72

News

See more

Yahoo Finance • 10 days ago

Fiserv Inc: A Significant Move in Jeff Auxier's Portfolio

Yahoo Finance • 15 days ago

Organon (OGN) Q4 2025 Earnings Call Transcript

Yahoo Finance • 16 days ago

Organon Q4 Earnings Preview: Cautious view amid weak year

Yahoo Finance • 3 months ago

Henlius and Organon Announce US FDA Approval of POHERDY® (pertuzumab-dpzb), the First PERJETA (pertuzumab) Biosimilar in the US

About

CEO
Mr. Joseph T. Morrissey Jr.
CFO
Mr. Matthew M. Walsh C.F.A.
Address
30 Hudson Street, Jersey City, NJ, United States, 07302
Sector
Healthcare
Industry
Drug Manufacturers - General
Full-Time Employees
10,000